The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
benzyl (S)-1-((S)-5-guanidino-1-oxo-1-(2-oxo-2H-chromen-7-ylamino)pentan-2-ylamino)-3-(4-guanidinophenyl)-1-oxopropan-2-ylcarbamate ID: ALA4517110
PubChem CID: 155540432
Max Phase: Preclinical
Molecular Formula: C33H37N9O6
Molecular Weight: 655.72
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(NC(=N)N)cc1)NC(=O)OCc1ccccc1)C(=O)Nc1ccc2ccc(=O)oc2c1
Standard InChI: InChI=1S/C33H37N9O6/c34-31(35)38-16-4-7-25(29(44)39-24-14-10-22-11-15-28(43)48-27(22)18-24)41-30(45)26(17-20-8-12-23(13-9-20)40-32(36)37)42-33(46)47-19-21-5-2-1-3-6-21/h1-3,5-6,8-15,18,25-26H,4,7,16-17,19H2,(H,39,44)(H,41,45)(H,42,46)(H4,34,35,38)(H4,36,37,40)/t25-,26-/m0/s1
Standard InChI Key: UDLXZPJASYUUAU-UIOOFZCWSA-N
Molfile:
RDKit 2D
48 51 0 0 0 0 0 0 0 0999 V2000
1.5917 -23.4055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5905 -24.2291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3027 -24.6422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0124 -24.2287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0096 -23.4019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3009 -22.9966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7249 -24.6403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4361 -24.2264 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1485 -24.6381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8597 -24.2242 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1498 -25.4594 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5722 -24.6358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2834 -24.2220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5735 -25.4572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2860 -25.8646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9959 -24.6336 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2821 -23.4007 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7029 -24.2198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4154 -24.6314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7016 -23.3985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4128 -22.9888 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9933 -22.9910 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4116 -22.1674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1266 -24.2176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8391 -24.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5503 -24.2153 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2627 -24.6270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9739 -24.2131 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2640 -25.4483 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1257 -21.7568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1248 -20.9362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7027 -21.7612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6982 -20.9420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4097 -20.5313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4076 -19.7138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6958 -19.3008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9885 -19.7157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9889 -20.5394 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2760 -19.3040 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2831 -26.6836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9947 -27.0951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7028 -26.6813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6989 -25.8557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9908 -25.4520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4158 -27.0919 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4182 -27.9132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1312 -28.3198 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7075 -28.3239 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
9 11 2 0
10 12 1 0
12 13 1 0
12 14 1 6
14 15 1 0
13 16 1 0
13 17 2 0
16 18 1 0
18 19 1 6
18 20 1 0
20 21 1 0
20 22 2 0
21 23 1 0
19 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
27 29 2 0
23 30 2 0
30 31 1 0
31 34 2 0
33 32 2 0
32 23 1 0
33 34 1 0
33 38 1 0
34 35 1 0
35 36 2 0
36 37 1 0
37 38 1 0
37 39 2 0
15 40 2 0
40 41 1 0
41 42 2 0
42 43 1 0
43 44 2 0
44 15 1 0
42 45 1 0
45 46 1 0
46 47 1 0
46 48 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 655.72Molecular Weight (Monoisotopic): 655.2867AlogP: 2.32#Rotatable Bonds: 14Polar Surface Area: 250.54Molecular Species: BASEHBA: 8HBD: 9#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 11#RO5 Violations (Lipinski): 3CX Acidic pKa: 12.06CX Basic pKa: 11.71CX LogP: 1.62CX LogD: -2.64Aromatic Rings: 4Heavy Atoms: 48QED Weighted: 0.04Np Likeness Score: -0.20
References 1. Cianni L, Feldmann CW, Gilberg E, Gütschow M, Juliano L, Leitão A, Bajorath J, Montanari CA.. (2019) Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity?, 62 (23): [PMID:31361135 ] [10.1021/acs.jmedchem.9b00683 ]